Alba Cantero-Perez
Tarragona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Analysis of the cyp51 genes contribution to azole resistance in Aspergillus section Nigri with the CRISPR-Cas9 technique.
Journal: Antimicrobial agents and chemotherapy
Published: March 09, 2021
Sarocladium and Acremonium infections: New faces of an old opportunistic fungus.
Journal: Mycoses
Published: June 04, 2020
Improvement of the pharmacokinetic/pharmacodynamic relationship in the treatment of invasive aspergillosis with voriconazole. Reduced drug toxicity through novel rapid release formulations.
Journal: Colloids and surfaces. B, Biointerfaces
Published: December 21, 2019
Azole resistance mechanisms in Aspergillus: update and recent advances.
Journal: International journal of antimicrobial agents
Published: April 22, 2019
New Insights into the Cyp51 Contribution to Azole Resistance in Aspergillus Section Nigri.
Journal: Antimicrobial agents and chemotherapy
Published: March 12, 2019
Current knowledge on the etiology and epidemiology of Scopulariopsis infections.
Journal: Medical mycology
Published: December 27, 2018
Efficacy, Biodistribution, and Nephrotoxicity of Experimental Amphotericin B-Deoxycholate Formulations for Pulmonary Aspergillosis.
Journal: Antimicrobial agents and chemotherapy
Published: March 12, 2018
Antifungal susceptibility of Saccharomyces cerevisiae and therapy in a murine model of disseminated infection.
Journal: Revista iberoamericana de micologia
Published: October 17, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026